Skip to main content

Grafa News and Videos — Page 1337

Latest

Grafa

Catalyst Pharmaceuticals secures Firdapse patent protection through 2035 in Hetero settlement

Catalyst Pharmaceuticals (NASDAQ:CPRX) and its licensor, SERB, have successfully resolved their patent litigation with Hetero and its affiliates regarding Firdapse (amifampridine) 10 mg tablets.

Read more: Catalyst Pharmaceuticals secures Firdapse patent protection through 2035 in Hetero settlement

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift